Similar articles for PMID: 19164238

Year	Number of Results
1985	2
1987	1
1989	1
1990	3
1991	3
1992	6
1993	9
1994	5
1995	4
1996	6
1997	9
1998	5
1999	7
2000	18
2001	22
2002	16
2003	16
2004	10
2005	15
2006	5
2007	17
2008	18
2009	12
2010	9
2011	5
2012	5
2013	8
2014	5
2015	6
2016	5
2017	7
2018	5
2019	2
2020	2
2021	2
2022	2
2023	4
2025	0

1

Myocardial beta-adrenergic receptor density assessed by 11C-CGP12177 PET predicts improvement of cardiac function after carvedilol treatment in patients with idiopathic dilated cardiomyopathy.

Naya M, Tsukamoto T, Morita K, Katoh C, Nishijima K, Komatsu H, Yamada S, Kuge Y, Tamaki N, Tsutsui H. Naya M, et al. J Nucl Med. 2009 Feb;50(2):220-5. doi: 10.2967/jnumed.108.056341. Epub 2009 Jan 21. J Nucl Med. 2009. PMID: 19164238 Free article.

2

Dobutamine stress 99mTc-tetrofosmin quantitative gated SPECT predicts improvement of cardiac function after carvedilol treatment in patients with dilated cardiomyopathy.

Kasama S, Toyama T, Kumakura H, Takayama Y, Ichikawa S, Tange S, Suzuki T, Kurabayashi M. Kasama S, et al. J Nucl Med. 2004 Nov;45(11):1878-84. J Nucl Med. 2004. PMID: 15534058 Free article. Clinical Trial.

3

Relation of early improvement in coronary flow reserve to late recovery of left ventricular function after beta-blocker therapy in patients with idiopathic dilated cardiomyopathy.

Sugioka K, Hozumi T, Takemoto Y, Ehara S, Ogawa K, Iwata S, Oe H, Matsumura Y, Otsuka R, Yoshiyama M, Yoshikawa J. Sugioka K, et al. Am Heart J. 2007 Jun;153(6):1080.e1-6. doi: 10.1016/j.ahj.2007.03.014. Am Heart J. 2007. PMID: 17540213

4

Plasma brain natriuretic peptide as a novel therapeutic indicator in idiopathic dilated cardiomyopathy during beta-blocker therapy: a potential of hormone-guided treatment.

Kawai K, Hata K, Takaoka H, Kawai H, Yokoyama M. Kawai K, et al. Am Heart J. 2001 Jun;141(6):925-32. doi: 10.1067/mhj.2001.115435. Am Heart J. 2001. PMID: 11376305

5

Carvedilol improves left atrial and left ventricular function and reserve in dilated cardiomyopathy after 1 year of treatment.

Paraskevaidis I, Farmakis D, Parissis JT, Dodouras T, Filippatos G, Tsiapras D, Kremastinos DT. Paraskevaidis I, et al. J Card Fail. 2007 Mar;13(2):108-13. doi: 10.1016/j.cardfail.2006.10.011. J Card Fail. 2007. PMID: 17395050

6

Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents.

Lowes BD, Gilbert EM, Abraham WT, Minobe WA, Larrabee P, Ferguson D, Wolfel EE, Lindenfeld J, Tsvetkova T, Robertson AD, Quaife RA, Bristow MR. Lowes BD, et al. N Engl J Med. 2002 May 2;346(18):1357-65. doi: 10.1056/NEJMoa012630. N Engl J Med. 2002. PMID: 11986409 Free article. Clinical Trial.

7

Myocardial contractile reserve under low doses of dobutamine and improvement of left ventricular ejection fraction with treatment by carvedilol.

Jourdain P, Funck F, Fulla Y, Hagege A, Bellorini M, Guillard N, Loiret J, Thebault B, Desnos M. Jourdain P, et al. Eur J Heart Fail. 2002 Jun;4(3):269-76. doi: 10.1016/s1388-9842(01)00239-2. Eur J Heart Fail. 2002. PMID: 12034151 Free article.

8

Arg389Gly-beta1-adrenergic receptors determine improvement in left ventricular systolic function in nonischemic cardiomyopathy patients with heart failure after chronic treatment with carvedilol.

Chen L, Meyers D, Javorsky G, Burstow D, Lolekha P, Lucas M, Semmler AB, Savarimuthu SM, Fong KM, Yang IA, Atherton J, Galbraith AJ, Parsonage WA, Molenaar P. Chen L, et al. Pharmacogenet Genomics. 2007 Nov;17(11):941-9. doi: 10.1097/FPC.0b013e3282ef7354. Pharmacogenet Genomics. 2007. PMID: 18075464

9

Myocardial contractile reserve by dobutamine stress echocardiography predicts improvement in ejection fraction with beta-blockade in patients with heart failure: the Beta-Blocker Evaluation of Survival Trial (BEST).

Eichhorn EJ, Grayburn PA, Mayer SA, St John Sutton M, Appleton C, Plehn J, Oh J, Greenberg B, DeMaria A, Frantz R, Krause-Steinrauf H. Eichhorn EJ, et al. Circulation. 2003 Nov 11;108(19):2336-41. doi: 10.1161/01.CIR.0000097111.00170.7B. Epub 2003 Nov 3. Circulation. 2003. PMID: 14597587

10

Recovery of the cardiac adrenergic nervous system after long-term beta-blocker therapy in idiopathic dilated cardiomyopathy: assessment by increase in myocardial 123I-metaiodobenzylguanidine uptake.

Lotze U, Kaepplinger S, Kober A, Richartz BM, Gottschild D, Figulla HR. Lotze U, et al. J Nucl Med. 2001 Jan;42(1):49-54. J Nucl Med. 2001. PMID: 11197980 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

262 results

Results by year

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Similar articles for PMID: 19164238

262 results

Results by year